| Question |
Answer |
| goal of antianginal therapy |
reduce myocardial oxygen consumption |
| name 5 determinants of antianginal therapy |
end diastolic volume, blood presure, heart rate, contractility, and ejection time |
| how do nitrates effect end diastolic volume, blood pressure, contractility, heart rate, and ejection time |
decrease EDV, decrease BP, increase contractility (reflex), increase HR (reflex), decrease Ejection time |
| how does beta-blocker affect end-diastolic volume, blood pressure, contractility, heart rate, ejection time |
increase EDV, decrease BP, decrease contractility, decrease HR, increase ejection time |
| name 3 factors that combo beta-blockers + nitrates will decrease |
blood pressure, heart rate, and overall myocardial oxygen consumption |
| for calcium channel blockers, what drug is similar to nitro |
nifedipine |
| for calcium channel blockers, what durg is similar to beta-blockers |
verapamil |
| define bioavailability, protein bound percentage, where excreted, and 1/2 life for digoxin |
75% availability, 20-40% bound, excreted in kidney, 40 hours t(1/2) |
| mechanism for digoxin |
block Na/K ATPase, increase Na, slow Na/Ca antiport, increases Ca in ECM, positive inotrope |
| how does digoxin affect ECG readings |
vagal effects increase PR, decrease QT, T wave inversion on ECG, and scooping of ST segment |
| name 2 uses for digoxin |
CHF (increase contractility) and A-Fib (decrease conduction at AV node) |
| 5 major general digoxin side efects |
nausea, vomiting, diarrhea, blurry yellow vision, arrhythmia |
| name 3 contraindications with digoxin |
renal failure, quinidine (will displace dig on protein, potentiate effect), hypokalemia (potentiate effect) |
| what is the antidote for digoxin |
slowly normalize K, lidocaine, cardiac pacer, anti-dig Fab fragments |
| describe function that all class I antiarrhythmics have |
decrease slope of phase 4 depolarization by blocking Na channels |
| define state dependency and state what drugs are state dependent |
class I antiarryhtmics. selectively depress tissue that is depolarized |
| name 4 class Ia antiarrhythmics |
Queen Amy Proclaims Diso's pyramid: quinidine, amiodarone, procainamide, disopyramide |
| name 3 mechanisms of class Ia antiarrhythmics |
increase AP duration, increase ERP, increase QT interval |
| what do you use class Ia antiarrhythmics for? |
atrial and ventricular arrhythmias |
| quinidine toxicities |
cinchonism: headache, tinnitisum, thrombocytopenia plus torsades |
| procainamide toxicity |
reversible lupus like side effect |
| name 3 class IB antiarrhythmics |
lidocaine, mexiletine, tocainide |
| mechanism for class IB |
decrease AP duration by blocking Na channel |
| where does class IB affect? |
affect ischemic or depolarized purkinje and ventricular tissue. |
| what is class IB useful for? |
acute ventricular arrhythmias (post-MI) and digitalis induced arrhythmia |
| name 4 side effects of class IB |
local anesthetic, cns stimulation, cns depression, cardiovascular depression |
| name 3 class IC antiarrhythmics |
flecainide, encainide, propafenone |
| name mechanism of class IC |
no effect on AP |
| what is class IC sueful for? |
v-tach that progress to V fib and also for SVT. usuaully only last resort for refractory tachyarrhythmias |
| class IC toxicities |
proarrhythmitic, especially post-MI (contraindiciated) |
| name 5 class II antiarrhythmics |
propanolol, esmolol, metoprolol, atenolol, timolol |
| mechanism of class II antiarrhythmics |
Beta-blockers; decrease cAMP, decrease Ca currents, decrease slope phase 4, increase PR interval at AV node |
| what is a short acting class II |
esmolol |
| name 5 side effects of class II drugs |
mask hypoglycema, impotence, asthma, CV effects (bradycardia, av block, chf). sleep alterations |
| name 4 class III antiarrhythmics |
sotalol, ibutilide, bretylium, amiodarone |
| mecanism of class III |
block K channels; increase AP duration, increase ERP, increase QT, used when others fail |